Biotoxtech Co., Ltd. provides safety evaluation services for pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. Its services include PK/TK, ADME, and RI analysis, validation and bioanalysis, efficacy evaluation and screening, clinical pathology and histopathology contracting, new drug development, and consulting and nonclinical trial support. Its safety evaluation research covers general, carcinogenicity, local, reproductive and developmental, genotoxicity, immunotoxicity, and juvenile animal toxicity studies, as well as safety pharmacology, ecotoxicology, and histopathology/clinical pathology. Founded in 2000, the company is headquartered in Cheongwon, South Korea.